Strategic Overview

Anbio is a Chinese diagnostics company developing point-of-care molecular tests for TB with innovative sample types.

Innovation Portfolio

POCT TB Test
Category: DIAGNOSIS Stage: Late Stage

Ultra-low-cost point-of-care molecular test for MTBC detection from tongue swab or sputum. Designed for maximal affordability and accessibility in resource-limited settings.

Molecular Swab/Sputum
POCT Sputum TB/RIF
Category: DRUG RESISTANCE Stage: Late Stage

Ultra-low-cost point-of-care molecular test for MTBC and rifampicin resistance detection from sputum. Designed for maximal affordability in resource-limited primary care settings.

Molecular Sputum

Key Milestones

POCT TB Test with tongue swab capability
95.79% sensitivity for tongue samples
POCT Sputum TB/RIF drug resistance test
Affordable cost of goods (≤$2.45-2.95)